News

Olema Oncology Set to Shine at Major Healthcare Conference

Olema Oncology Set to Shine at Major Healthcare Conference

Olema Oncology’s Upcoming Presentation at Renowned Conference

Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", NASDAQ: OLMA), a pioneering clinical-stage biopharmaceutical company, is gearing up to showcase its progress at the prominent J.P. Morgan Healthcare Conference. Scheduled for early January, this event is notable in the healthcare sector and attracts attention from a myriad of stakeholders, including investors, analysts, and industry leaders.

Leadership Showcase by Sean P. Bohen

At the heart of Olema's presentation will be Sean P. Bohen, M.D., who serves as the company's President and Chief Executive Officer. His insights about Olema's innovative approaches in oncology are highly anticipated, as he will delve into the advancements in targeted therapies for breast cancer and beyond. Held on January 14, 2025, this presentation is a prime platform for discussing the company's strategies and vision for the future.

A Focus on Innovations

Olema's commitment to revolutionizing treatment for breast cancer is reflected in its advanced pipeline of novel therapies. The lead product candidate, palazestrant (OP-1250), is a groundbreaking medication designed as a complete estrogen receptor antagonist and selective estrogen receptor degrader. It is currently undergoing Phase 3 trials in the OPERA-01 study, representing a crucial step toward better treatment outcomes.

A Call for Investor Engagement

The conference will feature a live webcast of Olema's presentation, ensuring that stakeholders can engage with the developments in real time. This initiative underscored Olema's transparency and dedication to keeping shareholders informed about its progress. The recording of the presentation will also be accessible on Olema's Investor Relations website for those unable to attend the live session.

Collaborative Efforts for Future Therapies

Beyond palazestrant, Olema is actively exploring additional avenues in therapeutic development, including a potent KAT6 inhibitor (OP-3136). This dedication to research and development illustrates Olema's unwavering focus on addressing the challenges presented in treating endocrine-driven cancers and improving patient care.

Olema’s Mission and Vision

At its core, Olema Oncology's mission revolves around enhancing the standard of care and significantly improving the outcome for patients afflicted by breast cancer. The company's initiatives hinge on a robust understanding of the mechanisms driving endocrine cancers, paving the way for innovative treatment modalities that can cater to patient needs more effectively.

Headquarters and Research Facilities

Olema is proudly headquartered in the vibrant city of San Francisco, California, with additional operational bases in Cambridge, Massachusetts. This geographical positioning allows for collaboration with leading research institutions and a connection to a thriving biotechnology community.

Contacting Olema Oncology

For inquiries, Olema's dedicated media and investor relations contact is Courtney O'Konek, the Vice President of Corporate Communications. She can be reached directly at media@olema.com. This line of communication ensures that those interested in Olema's journey can easily obtain insights and updates tailored to their interests.

Frequently Asked Questions

What is Olema Oncology known for?

Olema Oncology specializes in developing targeted therapies for breast cancer and other endocrine-driven cancers.

Who will present at the J.P. Morgan Healthcare Conference?

Sean P. Bohen, M.D., President and CEO of Olema, will deliver the presentation.

When will the presentation take place?

The presentation is scheduled for January 14, 2025, at 3:45 p.m. PT.

How can I watch the presentation?

You can view the live webcast on Olema's Investor Relations website.

What is Olema's lead product candidate?

Palazestrant (OP-1250) is Olema's lead product candidate currently in Phase 3 clinical trials.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SRG DocketWatch: Tracking FCC Docs in Real-Time

Updated Category News Views 5

I'll admit it—sometimes the FCC moves like molasses uphill. But keeping track of what they're up to? That's where the real challenge lies. Summit Ridge Group has tossed a lifeline for anyone who's got skin in the game with their new service, SRG DocketWatch. Why SRG DocketWatch Hits the Mark If you're poking your head into more than a few of those 21,000 FCC...

Continue Reading
XPENG Eyes South Korea Entry with Industry Veteran

Updated Category News Views 142

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Continue Reading
New Study Exposes Grim Reality for Moderate Aortic Stenosis

Updated Category News Views 154

Uncovering the Stark Truth of Moderate Aortic Stenosis When you hear about heart issues, the last thing you want to think about is moderate anything. But this study out of San Diego sure throws a wrench in how we size up moderate aortic stenosis. Turns out these patients aren't just in a holding pattern—they're facing some serious storm clouds. High Stakes for...

Continue Reading
PG&E, Edison Push Liability Cap Amid Firestorm

Updated Category News Views 0

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Continue Reading
SecureSpace Expands into Dallas-Fort Worth Market

Updated Category News Views 25

A New Player in Dallas-Fort Worth SecureSpace Self Storage has stormed into the Dallas-Fort Worth area, ushering in a sizeable expansion with four brand-new locations. This move is big news for the self-storage operator, marking its very first foray into the Texan market and boosting its nationwide presence past that century mark – 101 stores and counting. Call it a...

Continue Reading
Vanity Fair Lingerie Reveals New Smoothing Bra

Updated Category News Views 91

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

Continue Reading
China-CEEC Forum Sparks Robust SME Partnerships

Updated Category News Views 46

There’s a fresh buzz around Cangzhou's efforts to galvanize business opportunities between China and Central and Eastern Europe. The 7th China-CEEC SME Forum, kicking off in this city of Hebei Province, isn’t just another meeting of the minds. Nope, it’s like a marketplace thrown into overdrive—where AI strategies and logistics are shaping up to be the star...

Continue Reading
Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

Updated Category News Views 51

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

Continue Reading
Dun & Bradstreet's Merger Sparks Legal Showdown

Updated Category News Views 19

Shake-Up in Investor Circles Over D&B Class Action Lemme tell ya, Dun & Bradstreet Holdings (NYSE:DNB)—that name is echoing through courtrooms these days. It's like watching an old time Wall Street brawler go a few rounds with a heavyweight. Investors better sit tight because we've got a class action cooked up, and the lead plaintiff deadline smacks us in the face on...

Continue Reading
Mind Meets Soul: Neuroscience and Spiritual Pathways

Updated Category News Views 22

The Brain, Stress, and Spiritual Practices Ever tried to meditate and wondered if it actually does a number on your mind? Well, here comes Dr. Helen Lavretsky, who’s delving into the nitty-gritty of what happens up there when stress hits and spirituality steps in. This session on November 10 is bound to be a humdinger in the realm of science-meets-spirit. If you've ever...

Continue Reading

Top 5 Most Recently Viewed Articles

VIAVI Partners with Telefónica HISPAM for Network Enhancements

Updated Category News Views 73

VIAVI Enhances Network Management for Telefónica HISPAM VIAVI Solutions Inc. (VIAV) has entered a significant partnership with Telefónica HISPAM to streamline and automate network inventory management. Through this collaboration, VIAVI will leverage its NITRO AIOps technology to improve the oversight and management of network assets across diverse sectors. Automated...

Continue Reading
Economic Implications of Trump's Trade Deals Analyzed by Peter Schiff

Updated Category News Views 226

Unraveling the Economic Impact of Trade Deals Economist Peter Schiff expresses caution regarding President Donald Trump’s trade agreements, particularly those promoting the purchase of more U.S. goods. While these deals aim to bolster American exports, Schiff emphasizes the associated economic consequences that may affect consumers and investors alike. Key Concerns Over...

Continue Reading
Advancing Connectivity: The Impact of Xinghe Intelligent Network

Updated Category News Views 200

Xinghe Intelligent Network: A Game Changer for Carriers At a recent Ultra-Broadband Forum, a significant speech was delivered by Leon Wang, the President of Huawei's Data Communication Product Line. This address focused on the transformative role of the Xinghe Intelligent Network in the current advancement toward a Net5.5G era. Huawei's dedication to collaborating with...

Continue Reading
Yupp Video Services Revolutionizes Chaupal's Technology Framework

Updated Category News Views 297

Yupp Video Services Partners with Chaupal for Technology Upgrade Yupp Video Services (YVS), a global front-runner in white-label OTT platforms and streaming solutions, has partnered with Chaupal, a rapidly growing regional OTT platform focusing on Punjabi, Haryanvi, and Bhojpuri content. This collaboration signifies a major leap in Chaupal's evolution, as it revamps its...

Continue Reading
American Healthcare REIT Expands Operations with Trilogy Deal

Updated Category News Views 109

American Healthcare REIT Completes Major Acquisition American Healthcare REIT, Inc. (NYSE: AHR) has recently made a significant move in its business strategy by acquiring the remaining minority membership interest in Trilogy REIT Holdings, LLC. This acquisition marks an important development in the company's growth. Details of the Acquisition By exercising its purchase...

Continue Reading